TRIUMPH CAPITAL MANAGEMENT iShares Biotechnology ETF Transaction History

TRIUMPH CAPITAL MANAGEMENT portfolio value:

$2.11M
portfolio value

TRIUMPH CAPITAL MANAGEMENT quarter portfolio value change:

-0.57%
quarter

iShares Biotechnology ETF 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -21.90% -5.06K shares -607K $116.96 18.05K
Q2 2022 share Increase +57.98% 8.48K shares 812K $117.63 23.11K
Q1 2022 share Increase 0.00% 14.62K shares 1.90M $130.3 14.62K